Subject of the day
DMP.DE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
| Line | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | $290.67M | $302.40M | $272.15M | $294.90M |
| Gross profit | $193.18M | $199.19M | $184.13M | $195.83M |
| Operating income | $45.66M | $59.79M | $44.49M | $64.85M |
| Net income | $20.51M | $33.41M | $20.89M | $41.23M |
| Diluted EPS | — | 0.62 | 0.39 | — |
| Free cash flow | $59.84M | -$5.85M | $55.45M | $54.94M |
| CapEx | -$11.88M | -$10.07M | -$10.44M | -$9.72M |
$39.95
▼ -0.10 (-0.2%)
| 52w hi | $50.84 |
|---|---|
| 52w lo | $31.46 |
| Vol | 19.96K |
| As of | Aug 13 |
Our score +0.10
| Short | -0.09 |
|---|---|
| Medium | +0.21 |
| Long | +0.26 |
computed 2026-08-13
Dermapharm Holding SE
Healthcare · Drug Manufacturers - Specialty & Generic
| Market cap | $1.98B |
|---|---|
| Enterprise value | $2.96B |
| Trailing P/E | 14.91x |
| Forward P/E | 13.65x |
| EV / EBITDA | 10.93x |
| P / S (ttm) | 1.67x |
| Profit margin | 12.2% |
| Return on equity | 20.8% |
| Revenue growth | +1.3% |
| Earnings growth | +35.5% |
| Debt / equity | 141.39 |
| Beta vs SPX | 0.07 |
|---|---|
| Corr SPX | 0.04 |
| Annual vol | 29.5% |
| Annual ret | +15.1% |
| Sharpe | 0.51 |
| Max DD | -24.6% |
Window: 504 trading days (489 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.23 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $40.00 | $40.35 | $39.70 | $39.95 | 19.96K |
| Aug 12 | $40.10 | $40.45 | $39.90 | $40.05 | 31.27K |
| Aug 11 | $40.70 | $40.75 | $39.70 | $39.75 | 29.77K |
| Aug 10 | $40.50 | $41.35 | $40.30 | $40.50 | 31.31K |
| Aug 7 | $40.95 | $41.55 | $40.40 | $40.50 | 10.26K |